[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
|
[2] |
Hu HJ, Jin YW, Zhou RX, et al. Hepatic artery resection for bismuth typeⅢ andⅣhilar cholangiocarcinoma: is reconstruction always required?[J]. J Gastrointest Surg, 2018, 22(7):1204-1212.
|
[3] |
Vanwien A, Colard M, Godart J, et al. "Extended" right hepatectomy for primary cholangiocarcinoma of the liver[J]. Acta Chir Belg, 1964, 63:725-728.
|
[4] |
郑树国, 项灿宏, 冯晓彬, 等. 肝门部胆管癌诊断和治疗指南(2013版)[J]. 中华外科杂志, 2013, 51(10):865-871.
|
[5] |
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience[J]. Ann Surg, 2009, 250(2):187-196.
|
[6] |
Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery[J]. Surgery, 2011, 149(5):680-688.
|
[7] |
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6 336 patients and results of a survey[J]. Ann Surg, 2004, 240(2):205-213.
|
[8] |
Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver[J]. Surg Gynecol Obstet, 1975, 140(2):170-178.
|
[9] |
Jarnagin WR, Fong Y, Dematteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma[J]. Ann Surg, 2001, 234(4):507-517.
|
[10] |
Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers[J]. Ann Surg Oncol, 2018, 25(4):845-847.
|
[11] |
Deoliveira ML, Schulick RD, Nimura Y, et al. New staging system and a registry for perihilar cholangiocarcinoma[J]. Hepatology, 2011, 53(4):1363-1371.
|
[12] |
Shinohara K, Ebata T, Shimoyama Y, et al. Proposal for a new classification for perihilar cholangiocarcinoma based on tumour depth[J]. Br J Surg, 2019, 106(4):427-435.
|
[13] |
Takahashi T, Iizuka M, Sato H, et al. Doppler echocardiographic-determined changes in left ventricular diastolic filling flow velocity during the lower body positive and negative pressure method[J]. Am J Cardiol, 1990, 65(3):237-241.
|
[14] |
Kikuchi Y, Matuyama R, Hiroshima Y, et al. Surgical and histological boundary of the hepatic hilar plate system: basic study relevant to surgery for hilar cholangiocarcinoma regarding the "true" proximal ductal margin[J]. J Hepatobiliary Pancreat Sci, 2019, 26(5):159-168.
|
[15] |
Wakai T, Shirai Y, Moroda T, et al. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma[J]. Cancer, 2005, 103(6):1210-1216.
|
[16] |
Cheng QB, Yi B, Wang JH, et al. Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type Ⅲ and Ⅳ[J]. Eur J Surg Oncol, 2012, 38(12):1197-1203.
|
[17] |
Kow AW, Wook CD, Song SC, et al. Role of caudate lobectomy in type ⅢA and ⅢB hilar cholangiocarcinoma: a 15-year experience in a tertiary institution[J]. World J Surg, 2012, 36(5):1112-1121.
|
[18] |
Birgin E, Rasbach E, Reissfelder C, et al. A systematic review and meta-analysis of caudate lobectomy for treatment of hilar cholangiocarcinoma[J]. Eur J Surg Oncol, 2020, 46(5):747-753.
|
[19] |
Neuhaus P, Thelen A, Jonas S, et al. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma[J]. Ann Surg Oncol, 2012, 19(5):1602-1608.
|
[20] |
Tamoto E, Hirano S, Tsuchikawa T, et al. Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma[J]. HPB, 2014, 16(1):56-61.
|
[21] |
De Lu C, Huang J, Wu SD, et al. Total hilar en bloc resection with left hemihepatectomy and caudate lobectomy: a novel approach for treatment of left-sided perihilar cholangiocarcinoma (with video)[J]. J Gastrointest Surg, 2017, 21(11):1906-1914.
|
[22] |
Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections[J]. Ann Surg, 2013, 258(1):129-140.
|
[23] |
朱菁莪, 冯铭彬, 王捷, 等. 单中心不同时期肝门部胆管癌外科治疗患者预后及术式变化[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 9(1):36-40.
|
[24] |
Hadjis NS, Blenkharn JI, Alexander N, et al. Outcome of radical surgery in hilar cholangiocarcinoma[J]. Surgery, 1990, 107(6):597-604.
|
[25] |
胡海洁, 靳艳文, 林圯昕, 等. 肝门部胆管癌肿瘤直径及相关预后指标对患者预后的影响因素分析[J]. 中华消化外科杂志, 2018, 17(3):266-272.
|
[26] |
Marrelli D, Caruso S, Pedrazzani C, et al. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions[J]. Am J Surg, 2009, 198(3):333-339.
|